Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines

Author： Xiong Xishan   Ye Yangliang   Fu Lili   Dai Bing   Liu Jieqiong   Jia Jieshuang   Tang Jing   Li Lin   Wang Li   Shen Jianhua   Mei Changlin  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.27, Iss.3, 2009-06, pp. : 223-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 19, 2012-10 ,pp. : 2037-2048

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic diterpene derivatives from kaura-9(11),16-dien-19-oic acid: Cytostatic and cytotoxic activity against human cancer cell lines

By Alonso R.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 9, 2006-09 ,pp. : 476-479

Springer Publishing Company

Access to resources Recommend Favorite

Cytostatic and Cytotoxic Activity of Synthetic Diterpene Derivatives Obtained from (-)-Kaur-9(11), 16-Dien-19-Oic Acid Against Human Cancer Cell Lines

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 4, 2005-06 ,pp. : 255-259

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Anti-tumor Activities of Novel Phenyl Substituted Suberoylanilide Hydroxamic Acid Derivatives Against Human Cancer Cells

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 636-648

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments

By Hanauske Axel-Rainer   Oberschmidt Olaf   Hanauske-Abel Hartmut   Lahn Michael   Eismann Ulrike  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite